Nephrology

Htoo PT, Patorno E, Ortega-Montiel J, Wexler DJ, Orkaby A, Paik JM. Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2[...]

By afschroeder • September 30, 2026

Goshtaseb R, Luu Y, Sarmosyan K, Lopez L, Drakaki A. Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient[...]

By afschroeder • September 25, 2026

Goodrich J, Marçal J, Hestekin C, Hestekin J, Kurtz I. Engineering an Artificial Kidney. Clin J Am Soc Nephrol. 2026 Sep 24. doi: 10.2215/CJN.0000001251. Epub[...]

By afschroeder • September 25, 2026

Moy ML, Casaburi R, Nici L. Initial Results Do Not Support That Fully Virtual Pulmonary Rehabilitation Widens Reach to Underserved Patients With COPD. Chronic Obstr[...]

By afschroeder • September 25, 2026

Nissenson AR, Hegbrant J, Maddux FW, Strippoli GFM. Hemodialysis Care: Evolving to Enhance Patient-Level Outcomes. J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001286. Epub[...]

By afschroeder • September 23, 2026

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]

By afschroeder • September 22, 2026

Ortega-Montiel J, Alkabbani W, Hahn G, Liu J, Byrne CF, Wexler DJ, Patorno E, Paik JM. Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With[...]

By afschroeder • September 22, 2026

Mathew RO, Hong A, Narasaki Y, Fung E, Cheung D, Han J, Durstenfeld MS, Hsue PY, Rhee CM. Obesity and Cardio-Metabolic Health in Kidney Disease:[...]

By afschroeder • September 12, 2026

Cho H, Shin H, Najafzadeh M, Claggett B, Ortega-Montiel J, Liu J, Paik JM, Lalani NF, Bradley MC, Concato J, Solomon SD, Vardeny O, Patorno[...]

By afschroeder • September 7, 2026

Bea S, Patorno E, Sreedhara SK, Wexler DJ, Cromer SJ, Glynn RJ, Paik JM, Bykov K. Comparative Short-term Risk of Severe Gastrointestinal Events Associated With[...]

By sjmartinez • September 3, 2026